Bonnie van Wilgenburg

Principal at Monograph Capital

Speaker

Bonnie van Wilgenburg has nearly a decade of experience investing in and building therapeutics companies, most recently at Monograph and previously at Forbion. Her work spans company creation, drug development from discovery through commercialization, and multiple therapeutic areas. Prior to her investing career, Bonnie spent a decade as an academic immunologist at the University of Oxford and the University of Melbourne. She earned her DPhil from Oxford.